Is PAVmed Inc (PAVM) overvalued? · rev $55.0K
PAVmed Inc (PAVM) is a medical devices company listed on NASDAQ.
This page asks whether PAVmed Inc (PAVM) looks expensive on cached numbers — not a short thesis.
Latest reported PAVM revenue for 2026-06-30 was $55.0K. Net income was -$5.4M. PAVM currently screens at market cap $35.7M.
PAVM currently screens at market cap $35.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PAVM 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PAVM stock page for the full model, not this heading.
Not investment advice.